Aging population fuels these ETFs

There’s little doubt that the developing world’s aging population will continue to spend more on medical services for years to come. Medical device makers are well positioned to capture a share of that increased spending. In turn, investors in the industry’s leading companies stand to… Read More

Restructuring plan starts to pay off

BAXTER INTERNATIONAL INC. $70 (New York symbol BAX; Conservative Growth Portfolio, Manufacturing & Industry sector; Shares outstanding: 544.8 million; Market cap: $38.1 billion; Price-to-sales ratio: 3.7; Dividend yield: 0.9%; TSINetwork Rating: Average; www.baxter. com) makes a variety of medical devices, including intravenous pumps and kidney-dialysis… Read More

Medical device maker has a bright future

BAXTER INTERNATIONAL INC. $62 (New York symbol BAX; Conservative Growth Portfolio, Manufacturing & Industry sector; Shares outstanding: 544.9 million; Market cap: $33.8 billion; Price-to-sales ratio: 3.3; Dividend yield: 1.0%; TSINetwork Rating: Average; www.baxter. com) makes a variety of medical devices, including intravenous pumps and kidney-dialysis… Read More

TD HEALTH SCIENCES FUND $13.54

In 2017, mutual funds face increasing competition from ETFs as a low-cost alternative. But here’s a look back at a fund that continues to attract the same interest as it did here in May 2009…

TD HEALTH SCIENCES FUND $13.54 (CWA Rating: Speculative) (TD Asset Management, P.O. Box 7500, Station… Read More

Baxter expands its product line

BAXTER INTERNATIONAL INC. $50 (New York symbol BAX; Conservative Growth Portfolio, Manufacturing & Industry sector; Shares outstanding: 543.9 million; Market cap: $27.2 billion; Price-to-sales ratio: 2.7; Dividend yield: 1.1%; TSINetwork Rating: Average; www.baxter. com) will buy the injectable medicines business of India’s Claris Life sciences… Read More